422 related articles for article (PubMed ID: 30681346)
1. Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes.
Ingles J; Goldstein J; Thaxton C; Caleshu C; Corty EW; Crowley SB; Dougherty K; Harrison SM; McGlaughon J; Milko LV; Morales A; Seifert BA; Strande N; Thomson K; Peter van Tintelen J; Wallace K; Walsh R; Wells Q; Whiffin N; Witkowski L; Semsarian C; Ware JS; Hershberger RE; Funke B
Circ Genom Precis Med; 2019 Feb; 12(2):e002460. PubMed ID: 30681346
[TBL] [Abstract][Full Text] [Related]
2. Clinical features, spectrum of causal genetic mutations and outcome of hypertrophic cardiomyopathy in South Africans.
Ntusi NA; Shaboodien G; Badri M; Gumedze F; Mayosi BM
Cardiovasc J Afr; 2016; 27(3):152-158. PubMed ID: 27841901
[TBL] [Abstract][Full Text] [Related]
3. Evidence-Based Assessment of Genes in Dilated Cardiomyopathy.
Jordan E; Peterson L; Ai T; Asatryan B; Bronicki L; Brown E; Celeghin R; Edwards M; Fan J; Ingles J; James CA; Jarinova O; Johnson R; Judge DP; Lahrouchi N; Lekanne Deprez RH; Lumbers RT; Mazzarotto F; Medeiros Domingo A; Miller RL; Morales A; Murray B; Peters S; Pilichou K; Protonotarios A; Semsarian C; Shah P; Syrris P; Thaxton C; van Tintelen JP; Walsh R; Wang J; Ware J; Hershberger RE
Circulation; 2021 Jul; 144(1):7-19. PubMed ID: 33947203
[TBL] [Abstract][Full Text] [Related]
4. A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy.
Fokstuen S; Lyle R; Munoz A; Gehrig C; Lerch R; Perrot A; Osterziel KJ; Geier C; Beghetti M; Mach F; Sztajzel J; Sigwart U; Antonarakis SE; Blouin JL
Hum Mutat; 2008 Jun; 29(6):879-85. PubMed ID: 18409188
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy.
Kaski JP; Syrris P; Esteban MT; Jenkins S; Pantazis A; Deanfield JE; McKenna WJ; Elliott PM
Circ Cardiovasc Genet; 2009 Oct; 2(5):436-41. PubMed ID: 20031618
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.
Zhao Y; Cao H; Song Y; Feng Y; Ding X; Pang M; Zhang Y; Zhang H; Ding J; Xia X
Int J Mol Med; 2016 Jun; 37(6):1511-20. PubMed ID: 27082122
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and Phenotypic Expression of Mutations in the MYH7, MYBPC3 and TNNT2 Genes in Families with Hypertrophic Cardiomyopathy in the South of Brazil: A Cross-Sectional Study.
Mattos BP; Scolari FL; Torres MA; Simon L; Freitas VC; Giugliani R; Matte Ú
Arq Bras Cardiol; 2016 Sep; 107(3):257-265. PubMed ID: 27737317
[TBL] [Abstract][Full Text] [Related]
9. Additional value of screening for minor genes and copy number variants in hypertrophic cardiomyopathy.
Mademont-Soler I; Mates J; Yotti R; Espinosa MA; Pérez-Serra A; Fernandez-Avila AI; Coll M; Méndez I; Iglesias A; Del Olmo B; Riuró H; Cuenca S; Allegue C; Campuzano O; Picó F; Ferrer-Costa C; Álvarez P; Castillo S; Garcia-Pavia P; Gonzalez-Lopez E; Padron-Barthe L; Díaz de Bustamante A; Darnaude MT; González-Hevia JI; Brugada J; Fernandez-Aviles F; Brugada R
PLoS One; 2017; 12(8):e0181465. PubMed ID: 28771489
[TBL] [Abstract][Full Text] [Related]
10. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy.
Richard P; Charron P; Carrier L; Ledeuil C; Cheav T; Pichereau C; Benaiche A; Isnard R; Dubourg O; Burban M; Gueffet JP; Millaire A; Desnos M; Schwartz K; Hainque B; Komajda M;
Circulation; 2003 May; 107(17):2227-32. PubMed ID: 12707239
[TBL] [Abstract][Full Text] [Related]
11. Signal-to-Noise Analysis Can Inform the Likelihood That Incidentally Identified Variants in Sarcomeric Genes Are Associated with Pediatric Cardiomyopathy.
Kurzlechner LM; Jones EG; Berkman AM; Tadros HJ; Rosenfeld JA; Yang Y; Tunuguntla H; Allen HD; Kim JJ; Landstrom AP
J Pers Med; 2022 Apr; 12(5):. PubMed ID: 35629155
[TBL] [Abstract][Full Text] [Related]
12. Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy.
Núñez L; Gimeno-Blanes JR; Rodríguez-García MI; Monserrat L; Zorio E; Coats C; McGregor CG; Hernandez del Rincón JP; Castro-Beiras A; Hermida-Prieto M
Circ J; 2013; 77(9):2358-65. PubMed ID: 23782526
[TBL] [Abstract][Full Text] [Related]
13. Whole exome sequencing combined with integrated variant annotation prediction identifies a causative myosin essential light chain variant in hypertrophic cardiomyopathy.
Nomura A; Tada H; Teramoto R; Konno T; Hodatsu A; Won HH; Kathiresan S; Ino H; Fujino N; Yamagishi M; Hayashi K
J Cardiol; 2016 Feb; 67(2):133-9. PubMed ID: 26443374
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic disparity and identification of two TNNI3 gene mutations, one novel and one arising de novo, in South African patients with restrictive cardiomyopathy and focal ventricular hypertrophy.
Mouton JM; Pellizzon AS; Goosen A; Kinnear CJ; Herbst PG; Brink PA; Moolman-Smook JC
Cardiovasc J Afr; 2015; 26(2):63-9. PubMed ID: 25940119
[TBL] [Abstract][Full Text] [Related]
15. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR
Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and distribution of sarcomeric gene mutations in Japanese patients with familial hypertrophic cardiomyopathy.
Otsuka H; Arimura T; Abe T; Kawai H; Aizawa Y; Kubo T; Kitaoka H; Nakamura H; Nakamura K; Okamoto H; Ichida F; Ayusawa M; Nunoda S; Isobe M; Matsuzaki M; Doi YL; Fukuda K; Sasaoka T; Izumi T; Ashizawa N; Kimura A
Circ J; 2012; 76(2):453-61. PubMed ID: 22112859
[TBL] [Abstract][Full Text] [Related]
17. First identification of homozygous truncating CSRP3 variants in two unrelated cases with hypertrophic cardiomyopathy.
Janin A; Bessière F; Chauveau S; Chevalier P; Millat G
Gene; 2018 Nov; 676():110-116. PubMed ID: 30012424
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of Mutations in Hypertrophic Cardiomyopathy Genes Among Tunisian Patients.
Jaafar N; Gómez J; Kammoun I; Zairi I; Amara WB; Kachboura S; Kraiem S; Hammami M; Iglesias S; Alonso B; Coto E
Genet Test Mol Biomarkers; 2016 Nov; 20(11):674-679. PubMed ID: 27574918
[TBL] [Abstract][Full Text] [Related]
19. Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy.
Velicki L; Jakovljevic DG; Preveden A; Golubovic M; Bjelobrk M; Ilic A; Stojsic S; Barlocco F; Tafelmeier M; Okwose N; Tesic M; Brennan P; Popovic D; Ristic A; MacGowan GA; Filipovic N; Maier LS; Olivotto I
BMC Cardiovasc Disord; 2020 Dec; 20(1):516. PubMed ID: 33297970
[TBL] [Abstract][Full Text] [Related]
20. Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene.
Ehlermann P; Weichenhan D; Zehelein J; Steen H; Pribe R; Zeller R; Lehrke S; Zugck C; Ivandic BT; Katus HA
BMC Med Genet; 2008 Oct; 9():95. PubMed ID: 18957093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
